Atypical antipsychotics as add-on treatment in late-life depression

par Cakir S, Senkal Z
Publié 2016

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

par Ward K, Citrome L
Publié 2019

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life

par Montemagni C, Frieri T, Rocca P
Publié 2016

The Relationship between the Second-Generation Antipsychotics Efficacy and the Traditional Chinese Medicine Body Constitutions in Patients with Schizophrenia

par Tzu-Pei Yeh, Li-Chi Huang, Yu-Fen Chen, Jui-Fen Cheng
Publié 2021

VALIDATION OF A METHOD TO DETECT CENTRAL NERVOUS SYSTEM ACTING DRUGS IN BLOOD BY GC/MS. APPLICATION IN CASES OF DEATH CAUSED BY PHENOTHIAZINES IN THE NORTH OF CHILE

par BRAVO,FELIPE, ULLOA,ROBERTO, VENEGAS,KARINA, CONTZEN,MARIA CECILIA, RIOS,DAVID, BRICEÑO,MARGARITA, CALDERONI,PEDRO BUC, BENITES,JULIO
Publié 2014

Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, I...

par Bargagli AM, Cascini S, Agabiti N, Kirchmayer U, Marino C, Davoli M
Publié 2019

Fracturas de cadera en pacientes tratados con fármacos antipsicóticos. Estudio de cohortes históricas en Cataluña

par Susana González Tejón, Montserrat Ibarra Jato, M. Isabel Fernández San Martín, Albert Prats Uribe, Jordi Real Gatius, Luis Miguel Martin-Lopez
Publié 2022

Assessment of Antipsychotic Medications on Social Media: Machine Learning Study

par Miguel A. Alvarez-Mon, Miguel A. Alvarez-Mon, Miguel A. Alvarez-Mon, Carolina Donat-Vargas, Carolina Donat-Vargas, Javier Santoma-Vilaclara, Laura de Anta, Javier Goena, Javier Goena, Rodrigo Sanchez-Bayona, Fernando Mora, Fernando Mora, Miguel A. Ortega, Miguel A. Ortega, Guillermo Lahera, Guillermo Lahera, Guillermo Lahera, Guillermo Lahera, Roberto Rodriguez-Jimenez, Roberto Rodriguez-Jimenez, Roberto Rodriguez-Jimenez, Javier Quintero, Javier Quintero, Melchor Álvarez-Mon, Melchor Álvarez-Mon, Melchor Álvarez-Mon
Publié 2021

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia

par Kumsa A, Girma S, Alemu B, Agenagnew L
Publié 2020

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective

par Stephan Hjorth, Stephan Hjorth
Publié 2021

Effects of treatment with haloperidol and clozapine on the plasma concentrations of thyroid hormones in rats

par Samadi Afshin, Ziaee Mojataba, Isikhan Selen Yilmaz, Ulusu Nuriye Nuray, Samadi Mahshid
Publié 2020

Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term car...

par Aguiar JP, Heitor Costa L, Alves da Costa F, Leufkens HGM, Martins AP
Publié 2019

Development of a tool for monitoring the prescribing of antipsychotic medications to people with dementia in general practice: a modified eDelphi consensus study

par Jennings AA, Guerin N, Foley T
Publié 2018

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications

par Lei Chen, Lei Chen, Wen-Hui Zheng, Yang Du, Xue-Song Li, Yun Yu, Hua Wang, Yong Cheng, Yong Cheng
Publié 2021

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics

par Ping Yin, Chao Zhao, Yang Li, Xiaoyi Liu, Lei Chen, Nan Hong
Publié 2021

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia

par Stephanie Hsieh, Jing Yuan, Z. Kevin Lu, Minghui Li
Publié 2021

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis

par Bracha Erlanger Avigdor, Kun Yang, Ida Shinder, Benjamin C. Orsburn, Rana Rais, Shin-ichi Kano, Akira Sawa, Jonathan Pevsner
Publié 2021

COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES

par Shiraz Hussain, Nomita Imtiaz, Malik Awais Amin, Sana Khan, Siddique Kakar
Publié 2021

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms

par Octavian Vasiliu
Publié 2021

Use of atypical antipsychotics in the elderly: a clinical review

par Gareri P, Segura-Garcia C, Manfredi VG, Bruni A, Ciambrone P, Cerminara G, De Sarro G, De Fazio P
Publié 2014